Phase 1b Clinical Trial of IV OKN-007 in a Pilot Cohort of Human Recurrent Malignant Glioma Patients
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2013
At a glance
- Drugs Disufenton (Primary)
- Indications Glioma
- Focus Adverse reactions
- 01 Dec 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 18 Oct 2012 Planned initiation date changed from 1 Sep 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.
- 29 Aug 2012 New trial record